1
John L Faul, Toshihiko Nishimura, Peter N Kao, Ronald G Pearl: Implantable arterio-venous shunt devices and methods for their use. Rox Medical, James M Heslin, Adam W Bell, Matthew R Kaser, December 8, 2009: US07628768 (18 worldwide citation)

A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a bloo ...


2
John L Faul, Toshihiko Nishimura, Peter N Kao, Ronald G Pearl: Arterio-venous shunt devices. The Board of Trustees of the Leland Stanford Junior University, Adam Bell, James Heslin, Matthew Kaser, November 1, 2011: US08048016 (10 worldwide citation)

A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a bloo ...


3
Ronald G Pearl, Sun Yaojun: System and method for wireless delivery of text data. Smith Gambrell & Russell, Suite 3100 Promenade Ii, June 27, 2002: US20020083035-A1

The present invention discloses a system and method for the wireless delivery of text data from a file associated with a Uniform Resource Locator on a computer network.


4
John L Faul, Toshihiko Nishimura, Peter N Kao, Ronald G Pearl: Implantable arterio-venous shunt devices and methods for their use. The Board of Regents of The Leland Stanford Junior University, Bell & Associates, December 27, 2007: US20070299384-A1

A long-term implantable arterio-venous shunt device or creation of a fistula is provided that can be used as a therapeutic method for treating chronic obstructive pulmonary disease (COPD). The shunt device is implanted between an artery and a vein, preferably between a peripheral artery and the infe ...


5
John L Faul, Toshihiko Nishimura, Peter N Kao, Ronald G Pearl: Implantable arterio-venous shunt devices and methods for their use. Bell & Associates, May 19, 2005: US20050107733-A1

A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a bloo ...


6
Peter N Kao, Ronald G Pearl, Toshihiko Nishimura, John L Faul: Use of antiproliferative agents in the treatment and prevention of pulmonary proliferative vascular diseases. Bozicevic Field & Francis, June 2, 2005: US20050119330-A1

Methods of treating lung proliferative vascular disorders by administering an antiproliferative agent are provided. A preferred antiproliferative agent is a HMG-CoA reductase inhibitor, preferably simvastatin. Vascular occlusion in the pulmonary arteries of the patient is reduced as a result of the ...


7
John L Faul, Toshihiko Nishimura, Peter N Kao, Ronald G Pearl: Implantable arteriovenous shunt device. Lumen Intellectual Property Services, December 9, 2004: US20040249335-A1

A long-term implantable arteriovenous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a blood ...


8
John L Faul, Toshihiko Nishimura, Peter N Kao, Ronald G Pearl: Arterio-venous shunt devices. Bell & Associates, June 18, 2009: US20090156978-A1

A long-term implantable arterio-venous shunt device is provided that can be used as a therapeutic method. The shunt device is implanted between an artery and a vein, preferably between the aorta and the inferior vena cava. The shunt device decreases the systemic vascular resistance and allows a bloo ...